C. Anthony Blau

1.6k total citations
47 papers, 1.3k citations indexed

About

C. Anthony Blau is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, C. Anthony Blau has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Hematology and 17 papers in Genetics. Recurrent topics in C. Anthony Blau's work include Virus-based gene therapy research (16 papers), Platelet Disorders and Treatments (9 papers) and RNA Interference and Gene Delivery (9 papers). C. Anthony Blau is often cited by papers focused on Virus-based gene therapy research (16 papers), Platelet Disorders and Treatments (9 papers) and RNA Interference and Gene Delivery (9 papers). C. Anthony Blau collaborates with scholars based in United States, Germany and Israel. C. Anthony Blau's co-authors include Tobias Neff, Robert E. Richard, Liqing Jin, Thalia Papayannopoulou, Kevin G. Otto, Jonathan G. Drachman, Kenneth R. Peterson, David M. Spencer, David W. Emery and Hui Zeng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

C. Anthony Blau

46 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Anthony Blau United States 19 810 492 336 277 195 47 1.3k
Stephanie Laufs Germany 22 824 1.0× 574 1.2× 394 1.2× 209 0.8× 179 0.9× 59 1.3k
J. Düllmann Germany 14 948 1.2× 848 1.7× 346 1.0× 267 1.0× 118 0.6× 34 1.5k
Matthew P. McCormack Australia 18 642 0.8× 220 0.4× 319 0.9× 360 1.3× 315 1.6× 38 1.2k
Francesca Ficara Italy 16 1.2k 1.5× 786 1.6× 633 1.9× 316 1.1× 422 2.2× 43 1.9k
Patricia M. Rosten Canada 14 915 1.1× 168 0.3× 247 0.7× 310 1.1× 387 2.0× 17 1.4k
Denise Petersen United States 12 494 0.6× 340 0.7× 131 0.4× 230 0.8× 127 0.7× 16 819
Kunjlata M. Amin United States 23 649 0.8× 688 1.4× 417 1.2× 125 0.5× 243 1.2× 28 1.6k
Christian Vettermann United States 19 905 1.1× 639 1.3× 456 1.4× 358 1.3× 550 2.8× 36 1.7k
Sorin Armeanu Germany 19 880 1.1× 227 0.5× 289 0.9× 135 0.5× 403 2.1× 38 1.4k
Evelyne Lauret France 19 610 0.8× 125 0.3× 222 0.7× 240 0.9× 352 1.8× 49 1.2k

Countries citing papers authored by C. Anthony Blau

Since Specialization
Citations

This map shows the geographic impact of C. Anthony Blau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Anthony Blau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Anthony Blau more than expected).

Fields of papers citing papers by C. Anthony Blau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Anthony Blau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Anthony Blau. The network helps show where C. Anthony Blau may publish in the future.

Co-authorship network of co-authors of C. Anthony Blau

This figure shows the co-authorship network connecting the top 25 collaborators of C. Anthony Blau. A scholar is included among the top collaborators of C. Anthony Blau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Anthony Blau. C. Anthony Blau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuliang, Julie Mathieu, Chao-Zhong Song, et al.. (2020). Metabolic Control over mTOR-Dependent Diapause-like State. Developmental Cell. 52(2). 236–250.e7. 92 indexed citations
2.
Belay, Eyayu, Brian Hayes, C. Anthony Blau, & Beverly Torok‐Storb. (2017). Human Cord Blood and Bone Marrow CD34+ Cells Generate Macrophages That Support Erythroid Islands. PLoS ONE. 12(1). e0171096–e0171096. 10 indexed citations
3.
Beard, Brian C., David W. Emery, Kerstin Schwarzwaelder, et al.. (2011). Long-term Regulation of Genetically Modified Primary Hematopoietic Cells in Dogs. Molecular Therapy. 19(7). 1287–1294. 13 indexed citations
4.
5.
Blau, C. Anthony, et al.. (2008). Using gene transfer to circumvent off-target effects. Gene Therapy. 15(10). 759–764. 11 indexed citations
6.
7.
Richard, Robert E., et al.. (2005). Collection of blood stem cells from patients with sickle cell anemia. Blood Cells Molecules and Diseases. 35(3). 384–388. 13 indexed citations
8.
Blau, C. Anthony, Carlos F. Barbas, Renee Neades, et al.. (2005). γ-Globin Gene Expression in Chemical Inducer of Dimerization (CID)-dependent Multipotential Cells Established from Human β-Globin Locus Yeast Artificial Chromosome (β-YAC) Transgenic Mice. Journal of Biological Chemistry. 280(44). 36642–36647. 22 indexed citations
9.
Gandhi, Manish J., et al.. (2005). Congenital amegakaryocytic thrombocytopenia in three siblings: molecular analysis of atypical clinical presentation. Experimental Hematology. 33(10). 1215–1221. 22 indexed citations
10.
Emery, David W., et al.. (2005). Selection with a regulated cell growth switch increases the likelihood of expression for a linked gamma-globin gene. Blood Cells Molecules and Diseases. 34(3). 235–247. 9 indexed citations
11.
Richard, Robert E., R. Angelo de Claro, James Yan, et al.. (2004). Differences in F36VMpl-Based in Vivo Selection among Large Animal Models. Molecular Therapy. 10(4). 730–740. 10 indexed citations
12.
Kiem, Hans‐Peter, Stephanie Sellers, Bobbie Thomasson, et al.. (2004). Long-Term Clinical and Molecular Follow-up of Large Animals Receiving Retrovirally Transduced Stem and Progenitor Cells: No Progression to Clonal Hematopoiesis or Leukemia. Molecular Therapy. 9(3). 389–395. 76 indexed citations
13.
Kohn, Donald B., Michel Sadelain, Cynthia E. Dunbar, et al.. (2003). American society of gene therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Molecular Therapy. 8(2). 180–187. 120 indexed citations
14.
Blau, C. Anthony, et al.. (2002). Limitations of a Mouse Model of Sickle Cell Anemia. Blood Cells Molecules and Diseases. 28(2). 146–151. 3 indexed citations
15.
Otto, Kevin G., et al.. (2001). Control of Myoblast Proliferation with a Synthetic Ligand. Journal of Biological Chemistry. 276(44). 41191–41196. 30 indexed citations
16.
Blau, C. Anthony. (2001). Adverse effects of G-CSF in sickle cell syndromes. Blood. 97(12). 3682–3682. 4 indexed citations
17.
Fink, Gershon, et al.. (2000). The sky is the limit: exercise capacity 10 years post-heart–lung transplantation. Transplantation Proceedings. 32(4). 733–734. 11 indexed citations
18.
Jin, Liqing, Tobias Neff, & C. Anthony Blau. (1999). Marrow sensitization to 5-fluorouracil using the ligands for Flt-3 and c-Kit. Experimental Hematology. 27(3). 520–525. 6 indexed citations
19.
Blau, C. Anthony & George Stamatoyannopoulos. (1996). Preemptive therapy for genetic disease. Nature Medicine. 2(2). 161–162. 10 indexed citations
20.
Blau, C. Anthony, Tobias Neff, & Thalia Papayannopoulou. (1996). The Hematological Effects of Folate Analogs: Implications for Using the Dihydrofolate Reductase Gene for In Vivo Selection. Human Gene Therapy. 7(17). 2069–2078. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephanie Laufs Breakdown of academic impact, for papers by J. Düllmann Breakdown of academic impact, for papers by Matthew P. McCormack Breakdown of academic impact, for papers by Francesca Ficara Breakdown of academic impact, for papers by Patricia M. Rosten Breakdown of academic impact, for papers by Denise Petersen Breakdown of academic impact, for papers by Kunjlata M. Amin Breakdown of academic impact, for papers by Christian Vettermann Breakdown of academic impact, for papers by Sorin Armeanu Breakdown of academic impact, for papers by Evelyne Lauret
Rankless by CCL
2026